User menu

Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.

Bibliographic reference Leal, Teresinha ; Bergamini, Gabriella ; Huaux, François ; Panin, Nadtha ; Noël, Sabrina ; et. al. Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.. In: Frontiers in immunology, Vol. 7, no.1, p. 499 (2016)
Permanent URL
  1. Lyczak J. B., Cannon C. L., Pier G. B., Lung Infections Associated with Cystic Fibrosis, 10.1128/cmr.15.2.194-222.2002
  2. Williams P., Quorum sensing, communication and cross-kingdom signalling in the bacterial world, 10.1099/mic.0.2007/012856-0
  3. Pamukcu A., Bush A., Buchdahl R., Effects ofPseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis, 10.1002/ppul.1950190103
  4. Henry Richard L., Mellis Craig M., Petrovic Lea, MucoidPseudomonas aeruginosa is a marker of poor survival in cystic fibrosis, 10.1002/ppul.1950120306
  5. Cochrane Database of Systematic Reviews : Protocols, 10.1002/14651858
  6. Chmiel James F., Aksamit Timothy R., Chotirmall Sanjay H., Dasenbrook Elliott C., Elborn J. Stuart, LiPuma John J., Ranganathan Sarath C., Waters Valerie J., Ratjen Felix A., Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-ResistantStaphylococcus aureus, Gram-Negative Bacteria, and Multiple Infections, 10.1513/annalsats.201402-050as
  7. Cochrane Database of Systematic Reviews : Protocols, 10.1002/14651858
  8. Khan T Z, Wagener J S, Bost T, Martinez J, Accurso F J, Riches D W, Early pulmonary inflammation in infants with cystic fibrosis., 10.1164/ajrccm.151.4.7697234
  9. ARMSTRONG DAVID S., GRIMWOOD KEITH, CARLIN JOHN B., CARZINO ROSEMARY, GUTIÈRREZ JOSE P., HULL JEREMY, OLINSKY ANTHONY, PHELAN ETHNA M., ROBERTSON COLIN F., PHELAN PETER D., Lower Airway Inflammation in Infants and Young Children with Cystic Fibrosis, 10.1164/ajrccm.156.4.96-11058
  10. Pillarisetti Naveen, Williamson Elizabeth, Linnane Barry, Skoric Billy, Robertson Colin F., Robinson Phil, Massie John, Hall Graham L., Sly Peter, Stick Stephen, Ranganathan Sarath, , Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis, 10.1164/rccm.201011-1892oc
  11. Belessis Yvonne, Dixon Barbara, Hawkins Glenn, Pereira John, Peat Jenny, MacDonald Rebecca, Field Penny, Numa Andrew, Morton John, Lui Kei, Jaffe Adam, Early Cystic Fibrosis Lung Disease Detected by Bronchoalveolar Lavage and Lung Clearance Index, 10.1164/rccm.201109-1631oc
  12. Wolter J, Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial, 10.1136/thorax.57.3.212
  13. Equi A, Balfour-Lynn IM, Bush A, Rosenthal M, Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial, 10.1016/s0140-6736(02)11081-6
  14. Saiman Lisa, Marshall Bruce C., Mayer-Hamblett Nicole, Burns Jane L., Quittner Alexandra L., Cibene Debra A., Coquillette Sarah, Fieberg Ann Yunker, Accurso Frank J., Campbell III Preston W., for the Macrolide Study Group, Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa : A Randomized Controlled Trial, 10.1001/jama.290.13.1749
  15. Saiman Lisa, Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosaA Randomized Controlled Trial, 10.1001/jama.2010.563
  16. Ratjen Felix, Saiman Lisa, Mayer-Hamblett Nicole, Lands Larry C., Kloster Margaret, Thompson Valeria, Emmett Peggy, Marshall Bruce, Accurso Frank, Sagel Scott, Anstead Michael, Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa, 10.1378/chest.12-0628
  17. Gillis R. J., Iglewski B. H., Azithromycin Retards Pseudomonas aeruginosa Biofilm Formation, 10.1128/jcm.42.12.5842-5845.2004
  18. Legssyer Rachida, Huaux François, Lebacq Jean, Delos Monique, Marbaix Etienne, Lebecque Patrick, Lison Dominique, Scholte Bob J, Wallemacq Pierre, Leal Teresinha, Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice, 10.1186/1465-9921-7-134
  19. van Doorninck, EMBO J, 14, 4403 (1995)
  20. Nicklas W., Baneux P., Boot R., Decelle T., Deeny A. A., Fumanelli M., Illgen-Wilcke B., Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units, 10.1258/0023677021911740
  21. Bergamini Gabriella, Di Silvestre Dario, Mauri Pierluigi, Cigana Cristina, Bragonzi Alessandra, De Palma Antonella, Benazzi Louise, Döring Gerd, Assael Baroukh Maurice, Melotti Paola, Sorio Claudio, MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects, 10.1039/c2ib00127f
  23. Lubamba Bob, Huaux François, Lebacq Jean, Marbaix Etienne, Dhooghe Barbara, Panin Nadtha, Wallemacq Pierre, Leal Teresinha, Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice, 10.1016/j.jcf.2012.03.003
  24. Ducret Axel, Oostveen Inge Van, Eng Jimmy K., Yates John R., Aebersold Ruedi, High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry, 10.1002/pro.5560070320
  25. Carr Steven, Aebersold Ruedi, Baldwin Michael, Burlingame Al, Clauser Karl, Nesvizhskii Alexey, The Need for Guidelines in Publication of Peptide and Protein Identification Data : Working Group On Publication Guidelines For Peptide And Protein Identification Data, 10.1074/mcp.t400006-mcp200
  26. Mauri P., Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers, 10.1096/fj.04-3000fje
  27. Hilario M., Kalousis A., Approaches to dimensionality reduction in proteomic biomarker studies, 10.1093/bib/bbn005
  28. Jain A. K., Murty M. N., Flynn P. J., Data clustering: a review, 10.1145/331499.331504
  29. Zhao Ying, Karypis George, Data Clustering in Life Sciences, 10.1385/mb:31:1:055
  30. Tan Hui-Leng, Regamey Nicolas, Brown Sarah, Bush Andrew, Lloyd Clare M., Davies Jane C., The Th17 Pathway in Cystic Fibrosis Lung Disease, 10.1164/rccm.201102-0236oc
  31. Ding Wei, Smulan Lorissa J., Hou Nicole S., Taubert Stefan, Watts Jennifer L., Walker Amy K., s-Adenosylmethionine Levels Govern Innate Immunity through Distinct Methylation-Dependent Pathways, 10.1016/j.cmet.2015.07.013
  32. Hevia Henar, Varela-Rey Marta, Corrales Fernando J., Berasain Carmen, Martínez-Chantar María L., Latasa M. Ujue, Lu Shelly C., Mato José M., García-Trevijano Elena R., Avila Matías A., 5′-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes, 10.1002/hep.20154
  33. Lopes Rafael L., Borges Thiago J., Araújo Jessica F., Pinho Nathana G., Bergamin Letícia S., Battastini Ana Maria O., Muraro Stéfanie P., Souza Ana Paula D., Zanin Rafael F., Bonorino Cristina, Extracellular Mycobacterial DnaK Polarizes Macrophages to the M2-Like Phenotype, 10.1371/journal.pone.0113441
  34. Meyer Magali, Huaux François, Gavilanes Ximena, van den Brûle Sybille, Lebecque Patrick, Lo Re Sandra, Lison Dominique, Scholte Bob, Wallemacq Pierre, Leal Teresinha, Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis, 10.1165/rcmb.2008-0155oc
  35. Hoiby N, Diffuse panbronchiolitis and cystic fibrosis: East meets West., 10.1136/thx.49.6.531
  36. Koyama H., Geddes D. M., Erythromycin and diffuse panbronchiolitis, 10.1136/thx.52.10.915
  37. Jaffé Adam, Bush Andrew, Anti‐inflammatory effects of macrolides in lung disease, 10.1002/ppul.1076
  38. Retsema J, Fu Wenchi, Macrolides: structures and microbial targets, 10.1016/s0924-8579(01)00401-0
  39. Poehlsgaard Jacob, Douthwaite Stephen, The bacterial ribosome as a target for antibiotics, 10.1038/nrmicro1265
  40. Tsai Wan C., Hershenson Marc B., Zhou Ying, Sajjan Umadevi, Azithromycin increases survival and reduces lung inflammation in cystic fibrosis mice, 10.1007/s00011-009-0015-9
  41. Imperi Francesco, Leoni Livia, Visca Paolo, Antivirulence activity of azithromycin in Pseudomonas aeruginosa, 10.3389/fmicb.2014.00178
  42. Pier G. B., Grout M., Zaidi T. S., Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung, 10.1073/pnas.94.22.12088
  43. Schroeder T. H., Lee M. M., Yacono P. W., Cannon C. L., Gerceker A. A., Golan D. E., Pier G. B., CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF- B translocation, 10.1073/pnas.092160899
  44. Pier G, CFTR mutations and host susceptibility to Pseudomonas aeruginosa lung infection, 10.1016/s1369-5274(02)00290-4
  45. Kelly, J Clin Microbiol, 28, 2017 (1990)
  46. Jekel Peter A., Weijer Wicher J., Beintema Jaap J., Use of endoproteinase Lys-C from Lysobacter enzymogenes in protein sequence analysis, 10.1016/0003-2697(83)90308-1
  47. Letoffe Sylvie, Redeker Virginie, Wandersman Cecile, Isolation and characterization of an extracellular haem-binding protein from Pseudomonas aeruginosa that shares function and sequence similarities with the Serratia marcescens HasA haemophore, 10.1046/j.1365-2958.1998.00885.x
  48. Marvig R. L., Damkiaer S., Khademi S. M. H., Markussen T. M., Molin S., Jelsbak L., Within-Host Evolution of Pseudomonas aeruginosa Reveals Adaptation toward Iron Acquisition from Hemoglobin, 10.1128/mbio.00966-14
  49. Motta Adriana, Schmitz Carla, Rodrigues Luiz, Ribeiro Flávia, Teixeira Cesar, Detanico Thiago, Bonan Carla, Zwickey Heather, Bonorino Cristina, Mycobacterium tuberculosis heat-shock protein 70 impairs maturation of dendritic cells from bone marrow precursors, induces interleukin-10 production and inhibits T-cell proliferation in vitro, 10.1111/j.1365-2567.2007.02564.x
  50. Stocki Pawel, Wang Xiao N., Dickinson Anne M., Inducible Heat Shock Protein 70 Reduces T Cell Responses and Stimulatory Capacity of Monocyte-derived Dendritic Cells, 10.1074/jbc.m111.307579
  51. Spiering R., van der Zee R., Wagenaar J., van Eden W., Broere F., Mycobacterial and mouse HSP70 have immuno-modulatory effects on dendritic cells, 10.1007/s12192-012-0397-4
  52. Chu Ju, Qian Jiangchao, Zhuang Yingping, Zhang Siliang, Li Yourong, Progress in the research of S-adenosyl-l-methionine production, 10.1007/s00253-012-4536-8
  53. Hueck, Microbiol Mol Biol Rev, 62, 379 (1998)
  54. Barbieri J. T., Sun J., Pseudomonas aeruginosa ExoS and ExoT, Reviews of Physiology, Biochemistry and Pharmacology ISBN:9783540231318 p.79-92, 10.1007/s10254-004-0031-7
  55. Sundin Charlotta, Thelaus Johanna, Bröms Jeanette E., Forsberg Åke, Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN, 10.1016/j.micpath.2004.10.005
  56. Engel Joanne, Balachandran Priya, Role of Pseudomonas aeruginosa type III effectors in disease, 10.1016/j.mib.2008.12.007
  57. Woods D. E., Hwang W. S., Shahrabadi M. S., Que J. U., Alteration of pulmonary structure by Pseudomonas aeruginosa exoenzyme S, 10.1099/00222615-26-2-133
  58. Woods, J Clin Microbiol, 24, 260 (1986)
  59. Sun Y., Karmakar M., Taylor P. R., Rietsch A., Pearlman E., ExoS and ExoT ADP Ribosyltransferase Activities Mediate Pseudomonas aeruginosa Keratitis by Promoting Neutrophil Apoptosis and Bacterial Survival, 10.4049/jimmunol.1102148
  60. Verove Julien, Bernarde Cédric, Bohn Yu-Sing Tammy, Boulay François, Rabiet Marie-Josèphe, Attree Ina, Cretin François, Injection of Pseudomonas aeruginosa Exo Toxins into Host Cells Can Be Modulated by Host Factors at the Level of Translocon Assembly and/or Activity, 10.1371/journal.pone.0030488
  61. Stellari Fabio, Bergamini Gabriella, Sandri Angela, Donofrio Gaetano, Sorio Claudio, Ruscitti Francesca, Villetti Gino, Assael Barouk M, Melotti Paola, Lleo Maria M, In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin, 10.1186/s12967-015-0615-9